Federal grants to Versiti Blood Health, Inc.
Versiti Blood Health, Inc. in Milwaukee, Wisconsin received $88.3 million in federal grants from fiscal 2021 to 2025, across 49 awards. Its largest program was Cardiovascular Diseases Research, with $67.8 million. In fiscal 2025 it was awarded $18.1 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$88.3 million
- Awards49
- Awarded in FY 2025$18.1 million
- Largest award$12.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 25 | $17.0 million |
| FY 2022 | 26 | $16.5 million |
| FY 2023 | 25 | $16.6 million |
| FY 2024 | 29 | $20.1 million |
| FY 2025 | 25 | $18.1 million |
Programs that fund Versiti Blood Health, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 27 | $67.8 million |
| Military Medical Research and Development | 3 | $4.1 million |
| Cancer Biology Research | 4 | $4.0 million |
| Biomedical Research and Research Training | 2 | $3.1 million |
| Trans-NIH Research Support | 1 | $2.7 million |
| Cancer Treatment Research | 2 | $2.4 million |
| Vision Research | 1 | $1.2 million |
| 21st Century Cures Act - Beau Biden Cancer Moonshot | 1 | $1.1 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 3 | $865,078 |
| Research Infrastructure Programs | 1 | $679,925 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 46 | $84.2 million |
| Department of Defense | 3 | $4.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Molecular and clinical glycobiology of the bone marrow environment - the life-long production of blood cells requires hematopoietic developmental programs guided by systemic and local signals to convey the dynamic need for these cells. How these signals are delivered within the intra-medullar niches | Cardiovascular Diseases Research | December 23, 2020 | $12.3 million |
| Zimmerman program on the biology of vwd | Cardiovascular Diseases Research | March 29, 2021 | $7.9 million |
| Molecular mechanisms of immune thrombocytopenia in transfusion medicine - overall component – project summary/abstract this revised application for a program project seeks support for a coordinated, multi-disciplinary investigation of molecular mechanisms that underly clinically important immune-med | Cardiovascular Diseases Research | July 31, 2024 | $5.1 million |
| Basic investigation and translational applications concerning the cell and molecular biology of blood and vascular cells | Cardiovascular Diseases Research | March 19, 2021 | $3.9 million |
| Pulmonary arteriole occlusion by platelet-neutrophil micro-emboli in acute chest syndrome | Cardiovascular Diseases Research | April 9, 2021 | $3.5 million |
| Association of tissue factor pathway inhibitor with endothelium | Cardiovascular Diseases Research | March 31, 2021 | $3.0 million |
| Endothelial RAP1 in the control of heart function - cardiovascular disease (CVD) is a global pandemic with over 26 million people affected worldwide. Critical for regulation of heart oxygenation and metabolism is the cross-talk between heart endothelial cells (ECS) and cardiomyocytes (CMS) and smoot | Cardiovascular Diseases Research | January 19, 2022 | $2.9 million |
| Tfpi, protein s, and plasma fixa in hormone-induced hypercoagulability - venous thromboembolism (VTE) in women taking oral contraceptives (OC) is a problem of broad clinical significance that is mediated, at least in part, by estrogen effects on the expression of blood coagulation proteins by the li | Cardiovascular Diseases Research | July 16, 2021 | $2.8 million |
| Development of a b cell therapeutic | Trans-NIH Research Support | July 28, 2021 | $2.7 million |
| B-cell response and thrombotic complications in COVID-19 - abstract COVID-19 severity/lethality is associated with a dysfunctional inflammatory immune response and a hyper- engagement of pathways driving hemostasis and thrombosis, but the link between the two manifestations is not understood. Compar | Cardiovascular Diseases Research | January 18, 2022 | $2.6 million |
Questions people ask
How much federal grant money does Versiti Blood Health, Inc. get?
$88.3 million in 49 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Versiti Blood Health, Inc. the most?
The Department of Health and Human Services, with $84.2 million in 46 awards. The Department of Defense follow.
What is Versiti Blood Health, Inc.'s largest federal grant?
$12.3 million under Cardiovascular Diseases Research, with its first action in the period on December 23, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Versiti Blood Health, Inc.?
Its largest are Cardiovascular Diseases Research, Military Medical Research and Development and Cancer Biology Research.
Other grant recipients in Milwaukee
- The Medical College of Wisconsin, Inc.
- Milwaukee County
- City of Milwaukee
- United Migrant Opportunity Services/Umos Inc.
- University of Wisconsin System
- Marquette University
- Milwaukee County, Wisconsin
- Harley Davidson Inc
Largest federal grant recipients in Wisconsin · Federal grants in Wisconsin